After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
CADL belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Candel Therapeutics Inc is $297.98M. A total of 0.74 million shares were traded on the day, compared to an average of 3.83M shares.
In the most recent transaction, Barone Francesca sold 13,534 shares of CADL for 7.22 per share on Jan 15 ’25. After the transaction, the Chief Scientific Officer now owns 110,673 company shares. In a previous transaction on Jan 15 ’25, Tyagarajan Seshu sold 14,322 shares at 7.22 per share. CADL shares that Chief Technology Officer owns now total 96,790.
Among the insiders who sold shares, Schoch Charles disposed of 9,511 shares on Jan 15 ’25 at a per-share price of $7.22. This resulted in the insider holding 43,038 shares of CADL after the transaction. In another insider transaction, Tak Paul Peter sold 21,704 shares at $7.22 per share on Jan 15 ’25. Company shares held by the Chief Executive Officer now total 251,912.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, CADL has a high of $14.60 and a low of $1.16.
As of this writing, CADL has an earnings estimate of $0 per share for the current quarter.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. CADL’s latest balance sheet shows that the firm has $82.64M in Cash & Short Term Investments as of fiscal 2021. There were $560.00k in debt and $5.36M in liabilities at the time. Its Book Value Per Share was -$0.47, while its Total Shareholder’s Equity was $64.14M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CADL is Buy with a score of 5.00.
